Hyoscine butylbromide
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Hyoscine butylbromide and local guidelines before prescribing.
Mechanism
Antimuscarinic reducing smooth muscle spasm and secretions.
Uses
Abdominal colic, biliary or renal colic, death rattle, bowel obstruction in palliative care.
Dosing
- Pain and spasm: Antispasmodics - mebeverine 135 mg three times daily, hyoscine butylbromide, peppermint oil .
Gastroenterology: Bowel Disorders - Colic and secretions - hyoscine butylbromide 60–120 mg over 24 hours (antispasmodic and reduces secretions).
Palliative: Symptoms Management - Hyoscine butylbromide 60–120 mg/24 h SC | Bowel colic, secretions in obstruction, respiratory secretions.
Palliative: Symptoms Management - Respiratory secretions | Glycopyrronium 200 micrograms SC 4-hourly, or hyoscine butylbromide 20 mg SC hourly to 4-hourly (maximum 120 mg in 24 hours)
Palliative: End of Life Care
1 more dose entries from the chapters
- Hyoscine butylbromide SC 20 mg as needed (max 120 mg/24 h) | Secretions; bowel colic.
Palliative: End of Life Care
Side effects
Dry mouth, tachycardia, urinary retention, blurred vision.
Interactions
Other anticholinergics additive.
Contraindications and cautions
Narrow-angle glaucoma, myasthenia gravis, paralytic ileus
Monitoring
Heart rate
Pregnancy and breastfeeding
Acceptable
Renal and hepatic impairment
Caution in renal impairment
Overdose and reversal
Supportive
Special advice
Does not cross the blood-brain barrier so less confusion than hyoscine hydrobromide.
More from the textbook: uses, cautions and other points
- Bowel obstruction - avoid prokinetics (metoclopramide, domperidone) in complete obstruction; use cyclizine, haloperidol or hyoscine butylbromide.
Gastroenterology: Anatomy Physiology Pharmacology - Mebeverine / hyoscine butylbromide | IBS antispasmodics; Buscopan injection - caution in heart disease.
Gastroenterology: Anatomy Physiology Pharmacology - Bowel colic - hyoscine butylbromide (avoid stimulant laxatives in obstruction).
Palliative: Symptoms Management - Malignant bowel obstruction: opioid, hyoscine butylbromide, antiemetic, octreotide, dexamethasone trial - avoid metoclopramide with colic.
Palliative: Symptoms Management - Hyoscine (hydrobromide patch or butylbromide) | Antimuscarinic | Motion sickness (hydrobromide); colic and secretions in bowel obstruction (butylbromide) | Dry mouth, confusion in older people (hydrobromide), urinary retention, glaucoma
Gastroenterology: Anatomy Physiology Pharmacology - Antispasmodics - mebeverine , alverine, peppermint oil (can worsen reflux), hyoscine butylbromide (Buscopan - antimuscarinic; IM or IV injection can cause serious tachycardia and hypotension in patients with heart disease - MHRA).
Gastroenterology: Anatomy Physiology Pharmacology - MHRA Drug Safety Updates: PPIs, metoclopramide, domperidone, ondansetron, loperamide, hyoscine butylbromide injection, JAK inhibitors, terlipressin, clozapine
Gastroenterology: Anatomy Physiology Pharmacology - Otherwise medical management - see the Palliative Care chapter (hyoscine butylbromide, octreotide, dexamethasone, antiemetics, venting NG tube).
Oncology: Emergencies
Where it is discussed in the book
- Gastroenterology: Anatomy Physiology Pharmacology (5 mentions)
- Gastroenterology: Bowel Disorders (1 mention)
- Oncology: Emergencies (1 mention)
- Palliative: Symptoms Management (6 mentions)
- Palliative: End of Life Care (5 mentions)
- ENT: Emergencies (1 mention)
- Medicine of the older adult: .Prescribing and deprescribing in older people (1 mention)
- Medicine of the older adult. Discharge, capacity, advance care planning and end of life (1 mention)
- Critical care: common problems, ethics and recovery (1 mention)
- General Practice: Mental health, safeguarding, certification and the law (1 mention)
- Physiology: Nerve, muscle and autonomic systems, exercise, pregnancy and ageing (1 mention)